Enhancement of the Prediction of Chemotherapy Prescribing Errors for Oncology Patients

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Inappropriate PrescribingClinical Oncology
Interventions
BEHAVIORAL

determine the incidence , type , and severity of prescribing errors in the oncology department

"patients' files are revised according to BCCA reference protocols to report errors which are categorized according to type,and severity including: BSA calculation, the eligibility of the chemotherapy protocol , the dosage form ,dosage , the modification of doses according to toxicity and laboratory data results ,frequency ,duration of treatment , intention of treatment , the omitted or duplicated medications ,and the drug interactions.~the impact of the risk factors on the incidence , and type of prescribing errors are studied including :The tumor type, Cancer stage , co morbid illness,The number of drugs in the treatment regimen ,The route of administration of chemotherapy ,Dosing Frequency of treatment, The toxicity of chemotherapy experienced by the patient, The number of abnormal lab data,The type of abnormal lab data ,the age of patient.~."

All Listed Sponsors
lead

hadeer ehab

OTHER

NCT02435290 - Enhancement of the Prediction of Chemotherapy Prescribing Errors for Oncology Patients | Biotech Hunter | Biotech Hunter